Erdogan MA, Yusuf D, Christy J, Solmaz V, Erdogan A, Taskiran E, et al
Reduced expression of UPRmt proteins HSP10, HSP60, HTRA2, OMA1, SPG7, and YME1L is associated with accelerated heart failure in humans
Randomization: AOD-9604 at doses 0.25, 0.5, 1.0 mg daily SC vs placebo
Effective treatment requires proper dosing titration, lab monitoring, management of side effects, and adjustments based on your individual response
Washington State Department of Social and Health Services
Can I self-adjust my semaglutide microdosing schedule if I tolerate dose increases well? No, you should not self-adjust your semaglutide microdosing schedule without consulting your prescriber, even if you tolerate dose increases without side effects